Evidence map›Paper›PMID 38954694›Full record

ArticlePLOS global public health2024

"We only trust each other": A qualitative study exploring the overdose risk environment among persons who inject drugs living with HIV in Nairobi, Kenya.

Megan Maurano, David Bukusi, Sarah Masyuko, Rose Bosire, Esther Gitau, Brandon L Guthrie, Aliza Monroe-Wise, Helgar Musyoki, Mercy Apiyo Owuor, Betsy Sambai and 5 more

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Megan MauranoDepartment of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0003-1013-7572
David BukusiVCT and HIV Care, Kenyatta National Hospital, Nairobi, Kenya.
Sarah MasyukoNational AIDS and STI Control Program (NASCOP), Ministry of Health, Nairobi, Kenya.ORCID https://orcid.org/0000-0002-9836-4616
Rose BosireCentre for Clinical Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Esther GitauSupport for Addictions Prevention and Treatment in Africa (SAPTA), Nairobi, Kenya.
Brandon L GuthrieDepartment of Global Health, University of Washington School of Public Health and School of Medicine, Seattle, Washington, United States of America.
Aliza Monroe-WiseDepartment of Global Health, University of Washington School of Public Health and School of Medicine, Seattle, Washington, United States of America.
Helgar MusyokiNational AIDS and STI Control Program (NASCOP), Ministry of Health, Nairobi, Kenya.
Mercy Apiyo OwuorUniversity of Washington Global Assistance Program-Kenya, Nairobi, Kenya.
Betsy SambaiUniversity of Washington Global Assistance Program-Kenya, Nairobi, Kenya.
William SinkeleSupport for Addictions Prevention and Treatment in Africa (SAPTA), Nairobi, Kenya.
Hanley KingstonDepartment of Global Health, University of Washington School of Public Health and School of Medicine, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0003-1181-5507
Carey FarquharDepartment of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America.ORCID https://orcid.org/0000-0001-8575-3439
Loice MbogoUniversity of Washington Global Assistance Program-Kenya, Nairobi, Kenya.
Natasha T Ludwig-BarronDepartment of Global Health, University of Washington School of Public Health and School of Medicine, Seattle, Washington, United States of America.

Funding

TRAINEESHIPS IN AIDS PREVENTION STUDIEST32MH019105 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carol Suzanne Camlin, Glenn-Milo Santos · 1989 to 2026
$15.3M
NIMH NIH HHS T32 MH019105
6 · The paper itself

Abstract

In Kenya, overdose remains a major public health concern with approximately 40% of persons who inject drugs (PWID) reporting personal overdoses. PWID living with HIV (PWID-LH) are particularly vulnerable to experiencing fatal and non-fatal overdoses because of the surrounding physical, social, economic, and political environments, which are not fully understood in Kenya. Through qualitative inquiry, this study characterizes Kenya's overdose risk environment. Participants were purposively recruited from a larger cohort study from September to December 2018 using the following inclusion criteria: HIV-positive, age ≥18 years, injected drugs in the last year, and completed cohort study visits. Semi-structured interviews explored experiences of personal and observed overdoses, including injection settings, sequence of events (e.g., pre-, during, and post-overdose), safety strategies, and treatment. Interviews were transcribed, translated (Swahili to English), reviewed, and analyzed thematically, applying a risk environment framework. Nearly all participants described personal and/or observed overdose experiences (96%) and heroin was the most frequently reported substance (79%). Overdose precursors included increased consumption, polysubstance use, recent incarceration, and rushed injections. There were also indications of female-specific precursors, including violence and accessing prefilled syringes within occupational settings. Overdose safety strategies included avoiding injecting alone, injecting drugs incrementally, assessing drug quality, and avoiding polysubstance use. Basic first-aid techniques and naloxone use were common treatment strategies; however, naloxone awareness was low (25%). Barriers to treatment included social network abandonment, police discrimination, medical stigma, fatalism/religiosity, medical and transportation costs, and limited access to treatment services. In Kenya, the overdose risk environment highlights the need for comprehensive overdose strategies that address the physical, social, economic, and political environments. Morbidity and mortality from overdose among PWID-LH could be reduced through overdose prevention initiatives that support harm reduction education, naloxone awareness, and access, destigmatization of PWID, and reforming punitive policies that criminalize PWID-LH.

Identifiers

PMID38954694
PMCPMC11218959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.